Department of Pathology
Edgar Engleman has not added Biography.
If you are Edgar Engleman and would like to personalize this page please email our Author Liaison for assistance.
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.
Blood Mar, 2002 | Pubmed ID: 11861263
In vivo manipulation of dendritic cells to induce therapeutic immunity.
Blood Mar, 2002 | Pubmed ID: 11861283
Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation.
Journal of virology Nov, 2002 | Pubmed ID: 12368346
Langerhans cells renew in the skin throughout life under steady-state conditions.
Nature immunology Dec, 2002 | Pubmed ID: 12415265
Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases.
Arteriosclerosis, thrombosis, and vascular biology Nov, 2002 | Pubmed ID: 12426210
Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.
Clinical immunology (Orlando, Fla.) Jan, 2003 | Pubmed ID: 12584045
Dendritic cell-based cancer immunotherapy.
Seminars in oncology Jun, 2003 | Pubmed ID: 12881809
Two isoforms of otubain 1 regulate T cell anergy via GRAIL.
Nature immunology Jan, 2004 | Pubmed ID: 14661020
Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.
The Journal of clinical investigation Mar, 2004 | Pubmed ID: 14991076
Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.
Nature medicine May, 2004 | Pubmed ID: 15098028
Using signaling pathways to overcome immune tolerance to tumors.
Science's STKE : signal transduction knowledge environment Jul, 2004 | Pubmed ID: 15252217
Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors.
Experimental hematology Feb, 2005 | Pubmed ID: 15676211
In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2005 | Pubmed ID: 15728471
Flk2+ myeloid progenitors are the main source of Langerhans cells.
Blood Feb, 2006 | Pubmed ID: 16263793
Breaking tolerance to tumors with dendritic cell-based immunotherapy.
Annals of the New York Academy of Sciences Nov, 2005 | Pubmed ID: 16394129
Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2006 | Pubmed ID: 16638867
[A possibility of overcoming local tumor immune tolerance by radiofrequency ablation in combination with intratumoral injection of naïve dendritic cell].
Gan to kagaku ryoho. Cancer & chemotherapy Nov, 2006 | Pubmed ID: 17212091
Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity.
Bioconjugate chemistry Jan-Feb, 2007 | Pubmed ID: 17226959
Natural killer cells trigger differentiation of monocytes into dendritic cells.
Blood Oct, 2007 | Pubmed ID: 17626840
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2007 | Pubmed ID: 17709494
Breaking self-tolerance to tumor-associated antigens by in vivo manipulation of dendritic cells.
Methods in molecular biology (Clifton, N.J.) , 2007 | Pubmed ID: 17876112
Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2007 | Pubmed ID: 17878358
Tolerance and chimerism after renal and hematopoietic-cell transplantation.
The New England journal of medicine Jan, 2008 | Pubmed ID: 18216356
Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2008 | Pubmed ID: 18768834
T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size.
Bioconjugate chemistry Jan, 2009 | Pubmed ID: 19102625
In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines.
Molecular pharmaceutics Jul-Aug, 2009 | Pubmed ID: 19415922
Chemoselective ligation in the functionalization of polysaccharide-based particles.
Journal of the American Chemical Society Aug, 2009 | Pubmed ID: 19591467
Normalization of obesity-associated insulin resistance through immunotherapy.
Nature medicine Aug, 2009 | Pubmed ID: 19633657
Obesity predisposes to Th17 bias.
European journal of immunology Sep, 2009 | Pubmed ID: 19662632
Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation.
Journal of immunology (Baltimore, Md. : 1950) Dec, 2009 | Pubmed ID: 19890041
Regulation of human Th9 differentiation by type I interferons and IL-21.
Immunology and cell biology Aug, 2010 | Pubmed ID: 20421880
Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2010 | Pubmed ID: 20534740
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2010 | Pubmed ID: 20615964
Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset.
Journal of immunology (Baltimore, Md. : 1950) Feb, 2011 | Pubmed ID: 21172865
The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP.
Blood Apr, 2011 | Pubmed ID: 21325602
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.
Nature medicine May, 2011 | Pubmed ID: 21499269
T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.
Blood Sep, 2011 | Pubmed ID: 21813450
Induced immune tolerance for kidney transplantation.
The New England journal of medicine Oct, 2011 | Pubmed ID: 21991976
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados